thrx posts

Feed

Analyst Calls: BBY, BF.B, EEP, K, ORLY, PGR, SLB, SWK, TAP ...

Analyst Upgrades

  • Stephens upgraded Schlumberger (SLB) to overweight from equal weight with an $80 price target, citing valuation and the company's international activity.
  • Roth Capital upgraded Synutra International (SYUT) to buy from hold, citing the company's improved outlook, increased market share and valuation. The firm has a $27 target on shares.
  • Oppenheimer upgraded Progressive (PGR) to perform from underperform as it believes the company's focus on growth could move shares higher in the near-term.
  • Inergy Holdings (NRGP) was upgraded to buy from hold at Wunderlich.
  • Best Buy (BBY) was upgraded to hold from sell at Societe Generale.
  • Vale SA (VALE) was upgraded to buy from hold at Canaccord.

Continue reading Analyst Calls: BBY, BF.B, EEP, K, ORLY, PGR, SLB, SWK, TAP ...

Market highlights for next week: YUM, AA, COST, PEP to report

Monday October 8
  • PDUFA date for Theravance Inc's (NASDAQ: THRX) Telavancin for complicated skin and soft tissue infections caused by gram-positive bacteria
Tuesday October 9
Wednesday October 10
Thursday October 11
Friday October 12

Analyst initiations: AKAM, BBBY, MFE and WSM

MOST NOTEWORTHY: VMware (VMW), Bed, Bath & Beyond (BBBY), Williams-Sonoma (WSM), Landstar System (LSTR) and Acadia Pharmaceuticals (ACAD) were the noteworthy initiations:
  • Robert W. Baird initiated coverage on VMware (NYSE: VMW) with a Neutral rating citing valuation.
  • Citigroup started Bed Bath & Beyond (NASDAQ: BBBY) with a Hold rating, and cited the increasing competitive environment, slowing square footage growth and the weak housing market.
  • Citigroup started Williams-Sonoma (NYSE: WSM) with a Sell rating and said the company has an inventory glut that could lead to markdown risk, there is raw material price inflation, and the weak housing market remains a material risk.
  • Wachovia is cautious on Landstar System's (NASDAQ: LSTR) near-term growth rates and difficult end markets, starting shares with a Market Perform rating.
  • Deutsche is positive on the potential of Acadia Pharmaceutical's (NASDAQ: ACAD) ACP-103 in schizophrenia, starting shares with a Buy rating...
OTHER INITIATIONS:
  • Raymond James initiated Akamai (NASDAQ: AKAM) with an Outperform and resumed coverage of McAfee (NYSE: MFE) with an Outperform rating.
Analyst summaries provided by TheFlyOnTheWall.com (subscription required).

Symbol Lookup
IndexesChangePrice
DJIA-89.2312,801.23
NASDAQ-23.352,903.88
S&P 500-9.311,342.64

Last updated: February 10, 2012: 11:40 PM

Hot Stocks

General Electric

18.875-0.255(-1.33)

Alcoa

10.29-0.35(-3.29)

Apple Inc

493.42+0.25(+0.05)

Google Inc 'A'

605.91-5.55(-0.91)

Bank of America

8.07-0.11(-1.34)

Wal-Mart Stores

61.90-0.06(-0.10)

Exxon Mobil Corp

83.80-1.08(-1.27)

Ford

12.44-0.25(-1.97)

Citigroup

32.925-0.735(-2.18)

IBM

192.42-0.71(-0.37)

Yahoo

16.14+0.14(+0.88)

Starbucks

48.82-0.38(-0.77)

Microsoft

30.495-0.275(-0.89)

Home Depot

45.33+0.06(+0.13)

DailyFinance Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

Page Loaded in 1328935214980 ms.